BioCentury | Jan 5, 2015
Company News

Daiichi Sankyo sales and marketing update

...levofloxacin, a synthetic broad-spectrum oral fluoroquinolone antibiotic targeting bacterial DNA gyrase and topoisomerase , as Cravit...
BioCentury | Oct 13, 2014
Clinical News

Cravit levofloxacin regulatory update

...subsidiary submitted an sNDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for oral Cravit...
...strains of bacteria. Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Product: Cravit levofloxacin ( oral Cravit...
BioCentury | Jan 2, 2012
Company News

First Pharmaceutical, Daiichi Sankyo, Ranbaxy sales and marketing update

...Ranbaxy received rights to market Daiichi's antibacterial agent oral Cravit levofloxacin in Malaysia. First Pharmaceutical, which...
Items per page:
1 - 3 of 3